1-o-hexadecyl-2-n-methylcarbamylphosphatidylcholine has been researched along with Corneal Neovascularization in 1 studies
1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine: biologically active analog of PAF; structure given in first source
Corneal Neovascularization: New blood vessels originating from the corneal blood vessels and extending from the limbus into the adjacent CORNEAL STROMA. Neovascularization in the superficial and/or deep corneal stroma is a sequel to numerous inflammatory diseases of the ocular anterior segment, such as TRACHOMA, viral interstitial KERATITIS, microbial KERATOCONJUNCTIVITIS, and the immune response elicited by CORNEAL TRANSPLANTATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, X | 1 |
| Ottino, P | 1 |
| Bazan, HE | 1 |
| Bazan, NG | 1 |
1 other study available for 1-o-hexadecyl-2-n-methylcarbamylphosphatidylcholine and Corneal Neovascularization
| Article | Year |
|---|---|
Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Topics: Animals; Antibodies; Azepines; Cattle; Cell Division; Cell Movement; Cells, Cultured; Corneal Neovas | 2004 |